PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health Jg. 23; S. S720 - S721
Hauptverfasser: Jommi, C., Fanelli, F., Pedone, M.P., Cipriani, F., Canonica, G.W.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Elsevier Inc 01.12.2020
Schlagworte:
Internal Medicine
ISSN:1098-3015, 1524-4733
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Author Fanelli, F.
Cipriani, F.
Canonica, G.W.
Jommi, C.
Pedone, M.P.
Author_xml – sequence: 1
  givenname: C.
  surname: Jommi
  fullname: Jommi, C.
  organization: Università del Piemonte Orientale and Pharmaceutical Observatory, Cergas, University of Bocconi, Milano, Italy
– sequence: 2
  givenname: F.
  surname: Fanelli
  fullname: Fanelli, F.
  organization: Sanofi SpA, Milan, Italy
– sequence: 3
  givenname: M.P.
  surname: Pedone
  fullname: Pedone, M.P.
  organization: Sanofi SpA, Milan, Italy
– sequence: 4
  givenname: F.
  surname: Cipriani
  fullname: Cipriani, F.
  organization: Sanofi SpA, Milan, MI, Italy
– sequence: 5
  givenname: G.W.
  surname: Canonica
  fullname: Canonica, G.W.
  organization: Humanitas University, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
BookMark eNqFkc9u1DAQhyNUJNrCE3DxCySM7fzxCoGE0pauVFHULGdr6kxah6y9srOr7nPwwjiUExLqaeby_Wbmm7PsxHlHWfaeQ8GB1x_GYjzgVAgQUIAq-ArKV9kpr0SZl42UJ6mHlcol8OpNdhbjCAC1FNVp9uv7XSdKtnkk1t7ddl3e-gMFfCB2OQxkZuYHdrHf2Wm_xXtmHdsEwtm6B9Z6erLxT7s57ogJtnbDhNstzj4c2YWNhJEi847NKX0942TRsW-J9g4ndk04zY-so3CwJo172pHr7bwP9DZ7PeAU6d3fep79uLrctNf5ze3XdfvlJjeigjLvTd8gcQkkFaraKMBVaXjdVCBLpQYirKq6B6mUMI0ahn5luLlvFEoShEaeZ_I51wQfY6BB74LdYjhqDnrxqke9eNWLVw1KL14T9emZorTawVLQ0VhyhnobkjDde_sC__kf3kzWWYPTTzpSHP0-JD1Rcx2FBt0tn1seJ9JVvIYmBXz8f8CL438D7lmtUw
ContentType Journal Article
Copyright 2020
Copyright_xml – notice: 2020
DBID 6I.
AAFTH
AAYXX
CITATION
DOI 10.1016/j.jval.2020.08.1904
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1524-4733
EndPage S721
ExternalDocumentID 10_1016_j_jval_2020_08_1904
S1098301520341607
1_s2_0_S1098301520341607
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6PF
7-5
7PT
8-1
8P~
8UM
AAEDT
AAEDW
AAFJI
AAFWJ
AAIKJ
AAKOC
AALRI
AAMMB
AAOAW
AAPFB
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABMAC
ABMMH
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACLOT
ACPRK
ACRLP
ACRPL
ACUHS
ACVFH
ACXQS
ADBBV
ADCNI
ADEZE
ADFHU
ADMUD
ADNMO
ADVLN
AEBSH
AEFGJ
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AEYQN
AFBPY
AFEBI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AFZJQ
AGHFR
AGQPQ
AGTHC
AGUBO
AGXDD
AGYEJ
AIDQK
AIDYY
AIEXJ
AIGII
AIIAU
AIIUN
AIKHN
AITUG
AJAOE
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AOMHK
APXCP
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EFKBS
EFLBG
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
KOM
LH4
M41
MO0
N9A
O-L
O9-
OAUVE
OIG
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SV3
T5K
TEORI
TUS
W99
WIN
WYUIH
XG1
YFH
Z5R
~G-
~HD
0SF
6I.
AACTN
AAFTH
AAHHS
ABVKL
ACCFJ
AEEZP
AEQDE
AFCTW
AFKWA
AIWBW
AJBDE
AJOXV
AMFUW
NCXOZ
RIG
SUPJJ
AAIAV
ABLVK
ABYKQ
AJBFU
AKYCK
IXIXF
LCYCR
AAYXX
ALUQN
CITATION
O8X
ID FETCH-LOGICAL-c2504-dcd7ae130e38a86c80a94c167503488feea556d03882c78ffd9c1cb78a3e2eac3
ISSN 1098-3015
IngestDate Sat Nov 29 07:03:07 EST 2025
Fri Feb 23 02:40:15 EST 2024
Sun Feb 23 10:18:50 EST 2025
Tue Oct 14 19:30:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2504-dcd7ae130e38a86c80a94c167503488feea556d03882c78ffd9c1cb78a3e2eac3
OpenAccessLink https://dx.doi.org/10.1016/j.jval.2020.08.1904
ParticipantIDs crossref_primary_10_1016_j_jval_2020_08_1904
elsevier_sciencedirect_doi_10_1016_j_jval_2020_08_1904
elsevier_clinicalkeyesjournals_1_s2_0_S1098301520341607
elsevier_clinicalkey_doi_10_1016_j_jval_2020_08_1904
PublicationCentury 2000
PublicationDate December 2020
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: December 2020
PublicationDecade 2020
PublicationTitle Value in health
PublicationYear 2020
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0006325
Score 2.280407
SourceID crossref
elsevier
SourceType Index Database
Publisher
StartPage S720
SubjectTerms Internal Medicine
Title PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1098301520341607
https://www.clinicalkey.es/playcontent/1-s2.0-S1098301520341607
https://dx.doi.org/10.1016/j.jval.2020.08.1904
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1524-4733
  dateEnd: 20201231
  omitProxy: false
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: AIEXJ
  dateStart: 20191101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6FFCEuCAqI8NIcUC_EUbx-rY9V2oogGqImVLmtHD_URI0TNUnV_g7-Bj-SmV2vbSAq9MDFclbedTbzZebzzuxnxj6QyP4044Hlxx633Dh1rdANppafCBejL3IUpcB3_iUYDMRkEg4bjR9mL8z1ZZDn4uYmXP1XU2MbGpu2zt7D3OWg2IDnaHQ8otnx-E-GH56NuKsqKXpnX0cjq0dFmlSZUwgVIzs82q5m6JSiKa12jBVtVNl_ksVUp2O9MNvPMwTMQifij3Qqx6QXPvY3eolkUNco3lwY76NElCkfXkiWGAZ8Hl1ulVCJ3oFZVfAsFqqwoNcpIRVRCY5qPOlULjxZ6kXY086wbO3NVvjL5vVri5UMXq8K0c6XtE3R4Xh178ydmnsdBbxbC9X40d4ZBvSKxLwzR_N16FYk04rUx62insn0_xYMyxJFU_02lzSIpEFkV0ga5AHb44EXiibbO-wfTz6Xkd931Et-y3kYlStVT_jHd9nNhGrsZvyUPSkeS-BQw-kZa6T5Pnt0WhRe7LODoZY4v23DuNqxt27DAQwr8fPb5-y7gh9dBL_CDzT8YJlBCT-Y5WDgBxX8gOAHHOrwAwM_WOaA8IMCfmDgBxp-UMAPavB7wb6dHI97n6zixR9WTIp6VhInQZQiu0odEQk_Ft0odGPbp5w7BpwsTSPP8xMSMuJxILIsCWM7ngYiclKOTMJ5yZo5gvEVAxF7AgcNXTshrmyLMHMd9ELcS5D7h16LtY0R5Erru8g7TN9irjGUNFuXMdhKBN7d3YJd3dJ14TfW0pZrLrtyRNgh6HCcKWk_tphf9iw4sea6f7vl6_tN7A17XP0l37Lm5mqbvmMP4-vNbH31vgD6T_WE1VU
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PRS24+The+CROSS-Coverage+Effect+of+Dupilumab+in+Treating+Coexisting+Type+2+Inflammatory+Diseases+on+the+Italian+National+Health+Service+Expenditure&rft.jtitle=Value+in+health&rft.au=Jommi%2C+C.&rft.au=Fanelli%2C+F.&rft.au=Pedone%2C+M.P.&rft.au=Cipriani%2C+F.&rft.date=2020-12-01&rft.issn=1098-3015&rft.volume=23&rft.spage=S720&rft.epage=S721&rft_id=info:doi/10.1016%2Fj.jval.2020.08.1904&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jval_2020_08_1904
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301520X00155%2Fcov150h.gif